Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Clostridium Infections | 20 | 2023 | 548 | 4.540 |
Why?
|
Inflammatory Bowel Diseases | 21 | 2023 | 2410 | 2.670 |
Why?
|
Feces | 16 | 2023 | 1394 | 2.510 |
Why?
|
Enterocolitis, Pseudomembranous | 4 | 2020 | 264 | 1.300 |
Why?
|
Colitis, Ulcerative | 5 | 2021 | 1901 | 1.010 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2020 | 187 | 0.690 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2023 | 1130 | 0.690 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2022 | 395 | 0.660 |
Why?
|
Crohn Disease | 3 | 2021 | 2301 | 0.630 |
Why?
|
Demography | 1 | 2022 | 1650 | 0.610 |
Why?
|
Abdominal Pain | 2 | 2023 | 1059 | 0.600 |
Why?
|
Gastroenterology | 3 | 2019 | 534 | 0.550 |
Why?
|
Diarrhea | 1 | 2023 | 1343 | 0.530 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 609 | 0.530 |
Why?
|
Placebos | 1 | 2020 | 1677 | 0.530 |
Why?
|
Biological Therapy | 2 | 2015 | 138 | 0.530 |
Why?
|
Medication Adherence | 3 | 2017 | 2055 | 0.520 |
Why?
|
Deception | 1 | 2016 | 99 | 0.520 |
Why?
|
Leukocyte L1 Antigen Complex | 3 | 2021 | 88 | 0.520 |
Why?
|
Research Subjects | 1 | 2016 | 238 | 0.480 |
Why?
|
Patient Dropouts | 1 | 2016 | 421 | 0.460 |
Why?
|
Colonoscopy | 4 | 2021 | 1365 | 0.450 |
Why?
|
Problem Solving | 1 | 2015 | 440 | 0.440 |
Why?
|
Organ Transplantation | 1 | 2023 | 1135 | 0.440 |
Why?
|
Recurrence | 7 | 2023 | 8333 | 0.410 |
Why?
|
Child | 24 | 2023 | 77478 | 0.400 |
Why?
|
Transplantation | 1 | 2013 | 217 | 0.400 |
Why?
|
Problem-Based Learning | 1 | 2015 | 359 | 0.400 |
Why?
|
Family | 1 | 2020 | 3144 | 0.350 |
Why?
|
Cost of Illness | 1 | 2017 | 1852 | 0.310 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2275 | 0.300 |
Why?
|
Tuberculosis, Gastrointestinal | 1 | 2006 | 20 | 0.290 |
Why?
|
Perception | 1 | 2013 | 1188 | 0.280 |
Why?
|
Mesenteric Arteries | 1 | 2006 | 183 | 0.270 |
Why?
|
Caregivers | 1 | 2017 | 2074 | 0.270 |
Why?
|
Aneurysm, Infected | 1 | 2006 | 85 | 0.270 |
Why?
|
Humans | 52 | 2023 | 742088 | 0.250 |
Why?
|
Adolescent | 17 | 2023 | 85649 | 0.240 |
Why?
|
Attitude to Health | 1 | 2011 | 2051 | 0.210 |
Why?
|
Self Care | 2 | 2018 | 786 | 0.200 |
Why?
|
Therapeutic Equipoise | 1 | 2020 | 28 | 0.190 |
Why?
|
Treatment Outcome | 11 | 2023 | 62966 | 0.190 |
Why?
|
Quality of Life | 3 | 2017 | 12730 | 0.190 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 7901 | 0.180 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2019 | 63 | 0.170 |
Why?
|
Clinical Competence | 1 | 2015 | 4681 | 0.170 |
Why?
|
Medication Therapy Management | 1 | 2019 | 127 | 0.160 |
Why?
|
Antitubercular Agents | 1 | 2006 | 1319 | 0.160 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2018 | 3915 | 0.150 |
Why?
|
Sick Leave | 1 | 2017 | 110 | 0.150 |
Why?
|
Adult | 17 | 2023 | 213712 | 0.150 |
Why?
|
Self Efficacy | 2 | 2018 | 610 | 0.150 |
Why?
|
Yersinia Infections | 1 | 2016 | 9 | 0.140 |
Why?
|
Yersinia enterocolitica | 1 | 2016 | 13 | 0.140 |
Why?
|
Young Adult | 10 | 2021 | 56350 | 0.140 |
Why?
|
Male | 21 | 2023 | 349538 | 0.140 |
Why?
|
Receptors, Interleukin-17 | 1 | 2016 | 69 | 0.130 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 256 | 0.130 |
Why?
|
Longevity | 1 | 2022 | 1069 | 0.130 |
Why?
|
Irritable Bowel Syndrome | 1 | 2020 | 445 | 0.130 |
Why?
|
Ethics, Research | 1 | 2016 | 190 | 0.120 |
Why?
|
Female | 21 | 2023 | 379592 | 0.120 |
Why?
|
Metagenomics | 1 | 2017 | 430 | 0.120 |
Why?
|
Cri-du-Chat Syndrome | 1 | 2012 | 13 | 0.110 |
Why?
|
Secondary Prevention | 1 | 2019 | 1520 | 0.110 |
Why?
|
Names | 1 | 2012 | 50 | 0.110 |
Why?
|
Failure to Thrive | 1 | 2012 | 136 | 0.100 |
Why?
|
Needs Assessment | 1 | 2018 | 1146 | 0.100 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15530 | 0.100 |
Why?
|
Gastrointestinal Tract | 1 | 2017 | 814 | 0.100 |
Why?
|
Retrospective Studies | 6 | 2023 | 77098 | 0.090 |
Why?
|
United States | 5 | 2022 | 69693 | 0.090 |
Why?
|
Students | 1 | 2020 | 1647 | 0.090 |
Why?
|
Consensus | 1 | 2019 | 2935 | 0.090 |
Why?
|
Prognosis | 4 | 2018 | 29010 | 0.080 |
Why?
|
Regression Analysis | 1 | 2018 | 6452 | 0.080 |
Why?
|
Administration, Oral | 1 | 2015 | 3913 | 0.080 |
Why?
|
Probiotics | 1 | 2011 | 351 | 0.080 |
Why?
|
Linear Models | 1 | 2017 | 5948 | 0.070 |
Why?
|
Disease Management | 1 | 2018 | 2450 | 0.070 |
Why?
|
Learning | 1 | 2016 | 1705 | 0.070 |
Why?
|
Safety Management | 1 | 2012 | 782 | 0.070 |
Why?
|
Jejunal Diseases | 1 | 2006 | 50 | 0.070 |
Why?
|
Bacteria | 1 | 2017 | 2102 | 0.070 |
Why?
|
Duodenal Diseases | 1 | 2006 | 102 | 0.070 |
Why?
|
Insurance, Health | 1 | 2017 | 2493 | 0.060 |
Why?
|
Registries | 1 | 2020 | 8077 | 0.060 |
Why?
|
Pediatrics | 1 | 2019 | 3462 | 0.060 |
Why?
|
Health Care Surveys | 1 | 2011 | 2451 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2017 | 21719 | 0.050 |
Why?
|
Social Support | 1 | 2012 | 2117 | 0.050 |
Why?
|
Aged | 5 | 2022 | 162944 | 0.050 |
Why?
|
Middle Aged | 8 | 2021 | 213127 | 0.050 |
Why?
|
Health Surveys | 1 | 2012 | 4030 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7276 | 0.050 |
Why?
|
Anxiety | 1 | 2016 | 4279 | 0.050 |
Why?
|
Metronidazole | 1 | 2022 | 217 | 0.050 |
Why?
|
Angiography | 1 | 2006 | 1636 | 0.050 |
Why?
|
Reproducibility of Results | 4 | 2021 | 19862 | 0.040 |
Why?
|
France | 1 | 2019 | 517 | 0.040 |
Why?
|
Donor Selection | 1 | 2019 | 201 | 0.040 |
Why?
|
Social Adjustment | 1 | 2020 | 630 | 0.040 |
Why?
|
Cohort Studies | 1 | 2020 | 40450 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2012 | 4369 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 24913 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 15494 | 0.030 |
Why?
|
Depression | 1 | 2016 | 7733 | 0.030 |
Why?
|
Toll-Like Receptor 1 | 1 | 2016 | 48 | 0.030 |
Why?
|
Intestinal Mucosa | 2 | 2018 | 3038 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2019 | 594 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2016 | 39004 | 0.030 |
Why?
|
North America | 1 | 2019 | 1249 | 0.030 |
Why?
|
Universities | 1 | 2020 | 953 | 0.030 |
Why?
|
Specimen Handling | 1 | 2019 | 692 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7153 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2019 | 1849 | 0.030 |
Why?
|
Chronic Disease | 2 | 2022 | 9144 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17400 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2384 | 0.030 |
Why?
|
Databases, Factual | 2 | 2019 | 7716 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 21596 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2021 | 57683 | 0.030 |
Why?
|
Living Donors | 1 | 2017 | 618 | 0.030 |
Why?
|
Infant | 3 | 2022 | 35070 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 2017 | 1465 | 0.030 |
Why?
|
Chicago | 1 | 2012 | 238 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3339 | 0.030 |
Why?
|
Professional-Patient Relations | 1 | 2017 | 736 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2006 | 12958 | 0.020 |
Why?
|
Biological Products | 1 | 2019 | 856 | 0.020 |
Why?
|
Phylogeny | 1 | 2017 | 2797 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1788 | 0.020 |
Why?
|
Pedigree | 1 | 2016 | 4646 | 0.020 |
Why?
|
Risk Factors | 3 | 2019 | 72145 | 0.020 |
Why?
|
Societies, Medical | 1 | 2019 | 3740 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4801 | 0.020 |
Why?
|
Health Services Research | 1 | 2012 | 1834 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3391 | 0.020 |
Why?
|
Incidence | 1 | 2022 | 20928 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15056 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3585 | 0.010 |
Why?
|
Parents | 1 | 2017 | 3387 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13403 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14720 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 25575 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 14554 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 40955 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18355 | 0.010 |
Why?
|
Pilot Projects | 1 | 2012 | 8297 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13256 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16331 | 0.010 |
Why?
|
Quality Improvement | 1 | 2012 | 3738 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 53187 | 0.010 |
Why?
|
Physicians | 1 | 2012 | 4554 | 0.010 |
Why?
|
Mice | 1 | 2016 | 81045 | 0.010 |
Why?
|
Animals | 1 | 2016 | 168561 | 0.000 |
Why?
|
Concepts
(156)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(28)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_